AbbVie, Inc. (ABBV)

295.03 +0.58 (+0.20%) USD  |  NYSE  |  Nov 13, 16:00
294.41 -0.62 (-0.21%) After-Hours: 19:59
More

AbbVie Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Annual Revenue Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2028 --
December 31, 2027 --
December 31, 2026 --
Date Value
December 31, 2025 --
December 31, 2024 --

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Biogen, Inc. Upgrade
Amgen, Inc. Upgrade
REGENXBIO, Inc. Upgrade